Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Acknowledgement to reviewers98
Refining long-term surveillance requirements in patients with differentiated thyroid cancer82
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression61
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms51
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs45
Acknowledgement to reviewers45
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients44
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas39
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing38
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications38
Prognostic of recurrence and survival in poorly differentiated thyroid cancer31
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells31
Update on the genetics of paragangliomas31
Targeting growth hormone in cancer: future perspectives30
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells30
Survival following resection of 10,244 lung neuroendocrine tumours: a population study30
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas30
Metabolically active brown adipose tissue in PPGL: an observational cohort study26
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts26
Radioiodine treatment: an historical and future perspective26
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation25
Peptide receptor radionuclide therapy in malignant insulinoma24
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells24
Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer23
CCL2 expression predicts clinical outcomes and regulates E-cadherin and angiogenesis in pituitary tumours23
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation23
Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet23
0.075350046157837